WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY – Get Free Report) shares gapped up before the market opened on Thursday . The stock had previously closed at $12.20, but opened at $12.5899. WuXi Biologics (Cayman) shares last traded at $11.93, with a volume of 425 shares traded.
Wall Street Analysts Forecast Growth
Separately, Zacks Research raised WuXi Biologics (Cayman) to a “hold” rating in a research report on Friday, August 28th. One analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, WuXi Biologics (Cayman) has a consensus rating of “Hold”.
View Our Latest Stock Report on WuXi Biologics (Cayman)
WuXi Biologics (Cayman) Stock Up 1.7%
WuXi Biologics (Cayman) Company Profile
WuXi Biologics (Cayman) is a global contract research, development and manufacturing organization (CRDMO) focused on biologic medicines. The company provides integrated services to pharmaceutical and biotechnology customers across the development cycle, from early-stage discovery and preclinical research through clinical development, regulatory support and commercial manufacturing.
Its capabilities include the development and production of monoclonal antibodies, recombinant proteins, vaccines, antibody-drug conjugates and other biologic modalities.
Recommended Stories
- Five stocks we like better than WuXi Biologics (Cayman)
- Insider Sales Eclipse $450M Across 3 AI Winners, With NVIDIA Leading the Pack
- GameStop’s Comeback Case Is Getting Interesting, But eBay Still Looks Stronger
- Why Braze’s Guidance Miss May Be a Gift for Investors
- This Corner of the Market Is Outperforming the Benchmark—And It’s Not AI
Receive News & Ratings for WuXi Biologics (Cayman) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi Biologics (Cayman) and related companies with MarketBeat.com's FREE daily email newsletter.
